Pacific Biosciences Of California (PACB) Amortization - Intangibles (2021 - 2026)

Pacific Biosciences Of California's Amortization - Intangibles history runs 6 years deep, the most recent figure standing at $183000.0 for Q1 2026.

• On a quarterly basis, Amortization - Intangibles fell 99.95% year-over-year to $183000.0 in Q1 2026; TTM through Mar 2026 was $2.0 million, a 99.44% decrease from a year earlier, with the FY2025 full-year figure at $364.5 million, up 3780.99% from the prior year.
• Amortization - Intangibles eased to $183000.0 in Q1 2026 per PACB's latest filing, from $833000.0 in the prior quarter.
• Across five years, Amortization - Intangibles topped out at $362.0 million in Q1 2025 and bottomed at -$4.0 million in Q4 2024.
• The 5-year median for Amortization - Intangibles is $787000.0 (2023), against an average of $26.8 million.
• Across the five-year window, Amortization - Intangibles slumped 173.56% in 2024 and soared 26857.71% in 2025, its largest moves.
• Year by year, Amortization - Intangibles stood at $183000.0 in 2022, then jumped by 2859.56% to $5.4 million in 2023, then slumped by 173.56% to -$4.0 million in 2024, then soared by 120.91% to $833000.0 in 2025, then sank by 78.03% to $183000.0 in 2026.
• Per Business Quant, the three latest PACB Amortization - Intangibles figures stand at $183000.0 (Q1 2026), $833000.0 (Q4 2025), and $833000.0 (Q3 2025).